Cusatuzumab, CAS 1864871-20-4

Product Description: Cusatuzumab is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML)[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Riether C, et al. Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents. Nat Med. 2020; 26(9):1459-1467.

CAS Number: 1864871-20-4

Molecular Weight: N/A

Compound Purity: 98.80

Research Area: Inflammation/Immunology

Solubility: H2O

Target: Apoptosis

• Artikelnummer: MEXHY-P99014-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99014-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK